Castañón A - Search Results

1

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK.

Cuzick J, Castañón A, Sasieni P. Cuzick J, et al. Among authors: castanon a. Br J Cancer. 2010 Mar 2;102(5):933-9. doi: 10.1038/sj.bjc.6605528. Epub 2010 Jan 26. Br J Cancer. 2010. PMID: 20104226 Free PMC article.

2

How many cervical cancers are prevented by treatment of screen-detected disease in young women?

Sasieni P, Castanon A, Parkin DM. Sasieni P, et al. Among authors: castanon a. Int J Cancer. 2009 Jan 15;124(2):461-4. doi: 10.1002/ijc.23922. Int J Cancer. 2009. PMID: 18844220

3

Screening and adenocarcinoma of the cervix.

Sasieni P, Castanon A, Cuzick J. Sasieni P, et al. Among authors: castanon a. Int J Cancer. 2009 Aug 1;125(3):525-9. doi: 10.1002/ijc.24410. Int J Cancer. 2009. PMID: 19449379

4

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data.

Sasieni P, Castanon A, Cuzick J. Sasieni P, et al. Among authors: castanon a. BMJ. 2009 Jul 28;339:b2968. doi: 10.1136/bmj.b2968. BMJ. 2009. PMID: 19638651 Free PMC article.

5

What is the right age for cervical cancer screening?

Sasieni P, Castañon A, Cuzick J. Sasieni P, et al. Among authors: castanon a. Womens Health (Lond). 2010 Jan;6(1):1-4. doi: 10.2217/whe.09.69. Womens Health (Lond). 2010. PMID: 20088724 Free article. No abstract available.

6

ACOG guidelines on cervical screening: a step in the right direction.

Sasieni P, Castañón A, Cuzick J. Sasieni P, et al. Among authors: castanon a. J Med Screen. 2010;17(2):55-6. doi: 10.1258/jms.2010.010054. J Med Screen. 2010. PMID: 20660430 No abstract available.

7

Safe thresholds for hybrid capture 2 test in primary cervical screening.

Sasieni P, Castanon A. Sasieni P, et al. Among authors: castanon a. BMJ. 2011 May 23;342:d2941. doi: 10.1136/bmj.d2941. BMJ. 2011. PMID: 21606137 No abstract available.

8

Single negative colposcopy: is it enough to rule out high-grade disease?

Mesher D, Tristram A, Castanon A, Beer H, Ashman S, Fielder H, Fiander A, Sasieni P. Mesher D, et al. Among authors: castanon a. J Med Screen. 2011;18(3):160-1. doi: 10.1258/jms.2011.011097. J Med Screen. 2011. PMID: 22045826 Clinical Trial.

9

Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial.

Castañon A, Tristram A, Mesher D, Powell N, Beer H, Ashman S, Rieck G, Fielder H, Fiander A, Sasieni P. Castañon A, et al. Br J Cancer. 2012 Jan 3;106(1):45-52. doi: 10.1038/bjc.2011.496. Epub 2011 Nov 10. Br J Cancer. 2012. PMID: 22075942 Free PMC article. Clinical Trial.

10

Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers.

Castanon A, Ferryman S, Patnick J, Sasieni P. Castanon A, et al. Cytopathology. 2012 Feb;23(1):13-22. doi: 10.1111/j.1365-2303.2011.00948.x. Cytopathology. 2012. PMID: 22243289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters